Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma

Tissue Antigens

Volumn 86, Issue 3, 2015, Pages 172-177

  Keating, S E ^a   Ni Chorcora C ^a   Dring, M M ^a   Stallings, R L ^b   O'Meara, A ^c   Gardiner, Clair M ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

Human leukocyte antigen; Killer immunoglobulin like receptor; Natural killer cell; Neuroblastoma

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS2; UNCLASSIFIED DRUG; HLA C ANTIGEN; KIR2DL2 PROTEIN, HUMAN; KIR2DS2 PROTEIN, HUMAN; LIGAND;

ALLOTYPE; ARTICLE; CANCER SUSCEPTIBILITY; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; ALLELE; CASE CONTROL STUDY; CENTROMERE; CONSERVED SEQUENCE; GENETIC PREDISPOSITION; GENETICS; TELOMERE;

ALLELES; CASE-CONTROL STUDIES; CENTROMERE; COHORT STUDIES; CONSERVED SEQUENCE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-C ANTIGENS; HUMANS; LIGANDS; NEUROBLASTOMA; RECEPTORS, KIR; RECEPTORS, KIR2DL2; TELOMERE;

EID: 84938972544     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12608     Document Type: Article

References (28)

1. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003: 3: 203-16.
2. Schwab M, Westermann F, Hero B, Berthold F. Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol 2003: 4: 472-80.
3. Matthay KK, Reynolds CP, Seeger RC et al. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. J Clin Oncol 2009: 27: 1007-13.
4. Castriconi R, Dondero A, Cilli M et al. Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice. Cancer Immunol Immunother 2007: 56: 1733-42.
5. Castriconi R, Dondero A, Corrias MV et al. Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction. Cancer Res 2004: 64: 9180-4.
6. Rossi AR, Pericle F, Rashleigh S, Janiec J, Djeu JY. Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12. Blood 1994: 83: 1323-8.
7. Sivori S, Parolini S, Marcenaro E et al. Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines. J Neuroimmunol 2000: 107: 220-5.
8. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002: 20: 217-51.
9. Trowsdale J. Genetic and functional relationships between MHC and NK receptor genes. Immunity 2001: 15: 363-74.
10. Winter CC, Long EO. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J Immunol 1997: 158: 4026-8.
11. Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci USA 1993: 90: 12000-4.
12. Moretta A, Vitale M, Bottino C et al. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 1993: 178: 597-604.
13. Gumperz JE, Barber LD, Valiante NM et al. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J Immunol 1997: 158: 5237-41.
14. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 1994: 180: 1235-42.
15. Moesta AK, Parham P. Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3. Front Immunol 2012: 3: 336.
16. Venstrom JM, Zheng J, Noor N et al. KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma. Clin Cancer Res 2009: 15: 7330-4.
17. Delgado DC, Hank JA, Kolesar J et al. Genotypes of NK cell KIR receptors, their ligands, and Fcgamma receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy. Cancer Res 2010: 70: 9554-61.
18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
19. Vilches C, Castano J, Gomez-Lozano N, Estefania E. Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments. Tissue Antigens 2007: 70: 415-22.
20. Tajik N, Shahsavar F, Nasiri M, Radjabzadeh MF. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. Int J Immunogenet 2010: 37: 159-68.
21. Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 1998: 161: 571-7.
22. Moesta AK, Norman PJ, Yawata M, Yawata N, Gleimer M, Parham P. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J Immunol 2008: 180: 3969-79.
23. Raffaghello L, Prigione I, Airoldi I et al. Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma. Neoplasia 2004: 6: 558-68.
24. Tarek N, Le Luduec JB, Gallagher MM et al. Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment. J Clin Invest 2012: 122: 3260-70.
25. Verheyden S, Bernier M, Demanet C. Identification of natural killer cell receptor phenotypes associated with leukemia. Leukemia 2004: 18: 2002-7.
26. Al Omar S, Middleton D, Marshall E et al. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors. Hum Immunol 2010: 71: 976-81.
27. Middleton D, Vilchez JR, Cabrera T et al. Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours. Tissue Antigens 2007: 69: 220-6.
28. Furue H, Matsuo K, Kumimoto H et al. Decreased risk of colorectal cancer with the high natural killer cell activity NKG2D genotype in Japanese. Carcinogenesis 2008: 29: 316-20.